SCHEMBL2494632

SCHEMBL2494632

CCCCCCCCCCCCOS(=O)(=O)OCCCCCCCCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 15/20 0.67
CA2 P00918 15/20 0.67
CA9 Q16790 13/20 0.67
CA12 O43570 4/20 0.67
CA7 P43166 4/20 0.67
CA14 Q9ULX7 4/20 0.67
CA3 P07451 3/20 0.67
CA4 P22748 3/20 0.67
CA6 P23280 3/20 0.67
CA5A P35218 3/20 0.67
CA5B Q9Y2D0 3/20 0.67
RECQL P46063 2/20 0.64
TSHR P16473 2/20 0.64
GLA P06280 1/20 0.64
HPGD P15428 1/20 0.64
MAPK1 P28482 1/20 0.64
EPHX2 P34913 1/20 0.64
BLM P54132 1/20 0.64
KDM4E B2RXH2 1/20 0.48
USP2 O75604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148280 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL3354 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL41458 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL17336090 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL474049 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL771183 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL143596 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL42396 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL147679 1.00 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL5199618 1.00 CA1 (0.67) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9393242-B2 Compositions for treatment of ear disorders and methods of use thereof OTIC PHARMA LTD. (IL) 2016-07-19 US disclosed
EP-1699431-B1 COMPOSITIONS FOR TREATMENT OF EAR DISORDERS AND METHODS OF USE THEREOF OTIC PHARMA LTD (IL) 2015-08-19 EP disclosed
US-8940321-B2 Compositions for treatment of ear disorders and methods of use thereof OTIC PHARMA LTD. (IL) 2015-01-27 US disclosed
US-20120252720-A1 COMPOSITIONS FOR TREATMENT OF EAR DISORDERS AND METHODS OF USE THEREOF OTIC PHARMA LTD. (IL) 2012-10-04 US disclosed
US-8030362-B2 Admixing a pharmaceutical agent with a foam forming agent; introducing the mixture of into a dispensing device; metered dose, external auditory meatus OTIC PHARMA LTD. (IL) 2011-10-04 US disclosed
US-20080075670-A1 Compositions for Treatment of Ear Disorders and Methods of Use Thereof OTIC PHARMA LTD. (IL) 2008-03-27 US disclosed
EP-1699431-A2 COMPOSITIONS FOR TREATMENT OF EAR DISORDERS AND METHODS OF USE THEREOF Eilat, Eran (IL) 2006-09-13 EP disclosed
WO-2005055921-A2 COMPOSITIONS FOR TREATMENT OF EAR DISORDERS AND METHODS OF USE THEREOF EILAT ERAN (IL) 2005-06-23 WO disclosed